Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 5 minute read Healthcare Industry News Encompass Health (NYSE: EHC) targets underserved Mississippi market with 50-bed rehabilitation expansion Discover why Encompass Health Corp. is expanding inpatient rehabilitation capacity in Mississippi and what it signals for post-acute care investors. bySrinathFebruary 15, 2026